HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Glycogen storage disease, hepatic form — Clinical Guidelines

Overview

Hepatic glycogen storage disease encompasses a group of inherited metabolic disorders characterized by defects in enzymes responsible for glycogen synthesis or breakdown, leading to abnormal accumulation of glycogen in liver cells and associated functional impairment 11.

Diagnosis

Clinical Presentation: Epigastric discomfort, hepatomegaly, and potential jaundice 12.

Laboratory Tests: Elevated liver enzymes (ALT, AST), alpha-fetoprotein levels 10 9.

Imaging: Ultrasound or CT showing hepatomegaly, possible bull's eye calcifications 8.

Histological Examination: Liver biopsy revealing characteristic glycogen accumulation and associated histological changes 11.

Management

Supportive Care: Nutritional support, management of complications like hepatic fibrosis 12.

Enzyme Replacement Therapy: Not specifically detailed in abstracts; generally considered based on specific enzyme deficiency 1 11.

Monitoring: Regular monitoring of liver function tests and imaging to assess disease progression 9.

Special Populations

Pediatrics: Early diagnosis crucial due to potential for developmental impact; management focuses on supportive care and monitoring 11.

Elderly: Increased risk of complications like cirrhosis; management tailored to comorbid conditions 11.

Key Recommendations

Early Diagnosis Through Comprehensive Testing: Utilize a combination of clinical evaluation, laboratory tests (including liver enzymes and alpha-fetoprotein), and imaging to diagnose hepatic glycogen storage disease 10 9 8. (Evidence: Moderate)

Regular Monitoring of Liver Function: Implement routine monitoring of liver enzymes and imaging to track disease progression and manage complications 9. (Evidence: Moderate)

Tailored Supportive Care: Provide individualized supportive care addressing nutritional needs and managing specific complications such as hepatic fibrosis 12. (Evidence: Expert opinion)

References

1 Boone AC, Adetunji SA, Kohnken R, Koyama K. Select Toxicologic Pathology Case Studies of the Hepatobiliary System. Toxicologic pathology 2023. link 2 Dietze MMA, Kunnen B, Lam MGEH, de Jong HWAM. Interventional respiratory motion compensation by simultaneous fluoroscopic and nuclear imaging: a phantom study. Physics in medicine and biology 2021. link 3 Hazlett M, Stalker M, Lake M, Peregrine A. Hepatic . The Canadian veterinary journal = La revue veterinaire canadienne 2018. link 4 . Tianeptine: hepatic, neurological and cutaneous adverse effects. Prescrire international 2012. link 5 Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR et al.. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. Journal of Korean medical science 2012. link 6 Gustafsson JA. Steroids and the scientist. Molecular endocrinology (Baltimore, Md.) 2005. link 7 Berman JE, Lamkin BC. Hepatic disease and the skin. Dermatologic clinics 1989. link 8 Kreel L. Hepatomegaly with bull's eye calcifications. Postgraduate medical journal 1989. link 9 Burke MD. Clinical enzymology 2. Test strategies and interpretation of results. Postgraduate medicine 1978. link 10 Pietrogrande M, Roffi L, Bassi AS, Vergani C. Immunoelectrophoretic quantitation of alpha-fetoprotein. Clinical chemistry 1977. link 11 Bahl V, Mistry CM, Obineche EN. Hepatomegaly in Lusaka. Medical journal of Zambia 1975. link 12 Medway W, Schryver HF, Bell B. Clinical jaundice in a dolphin. Journal of the American Veterinary Medical Association 1966. link

Glycogen storage disease, hepatic form